Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.03% | 19.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.03% | 19.78% | |||
| Cost of Revenue | -9.03% | -1.81% | |||
| Gross Profit | 131.75% | 157.15% | |||
| SG&A Expenses | -4.25% | -14.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | -7.60% | |||
| Operating Income | 103.67% | 41.55% | |||
| Income Before Tax | 89.64% | -39.56% | |||
| Income Tax Expenses | -2,616.67% | 106.52% | |||
| Earnings from Continuing Operations | 89.88% | -39.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -90.33% | 40.17% | |||
| Net Income | 89.54% | -39.62% | |||
| EBIT | 103.67% | 41.55% | |||
| EBITDA | 268.32% | 64.79% | |||
| EPS Basic | 89.63% | -39.30% | |||
| Normalized Basic EPS | -97.08% | 404.98% | |||
| EPS Diluted | 89.63% | -39.30% | |||
| Normalized Diluted EPS | -97.08% | 404.98% | |||
| Average Basic Shares Outstanding | 0.93% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.93% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||